Footwear conglomerate Wolverine Worldwide (NYSE:WWW) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 4.6% year on year to $517.5 million. The company’s full-year revenue guidance of $1.97 billion at the midpoint came in 0.

Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps delivering the hard truth.

Medical device company Integra LifeSciences (NASDAQ:IART) announced better-than-expected revenue in Q4 CY2025, but sales fell by 1.7% year on year to $434.9 million. On the other hand, next quarter’s revenue guidance of $382.5 million was less impressive,

Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on their secret sauce. But cutbacks in corporate spending and the threat of new AI products have kept sentiment in check, and over the p

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Clinical research company Fortrea Holdings (NASDAQ:FTRE) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 5.2% year on year to $660.5 million. The company’s full-year revenue guidance of $2.6 billion at the midpoint came in

Even if a company is profitable, it doesn’t always mean it’s a great investment. Some struggle to maintain growth, face looming threats, or fail to reinvest wisely, limiting their future potential.

Healthcare tech company Privia Health Group (NASDAQ:PRVA) announced better-than-expected revenue in Q4 CY2025, with sales up 17.4% year on year to $541.2 million. The company’s full-year revenue guidance of $2.4 billion at the midpoint came in 3.7% above

Filtration equipment manufacturer Donaldson (NYSE:DCI) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 3% year on year to $896.3 million. Its non-GAAP profit of $0.83 per share was 6.6% below analysts’ consensus estimates.

Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or even a loyal Reddit fanbase.

Energy drink company Celsius (NASDAQ:CELH) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 117% year on year to $721.6 million. Its non-GAAP profit of $0.26 per share was 36.9% above analysts’ consensus estimates.

Stocks that outperform the market usually share key traits such as rising sales, expanding margins, and increasing returns on capital. The select few that can do all three for many years are often the ones that make you life-changing money.

Luxury furniture retailer Arhaus (NASDAQ:ARHS) reported Q4 CY2025 results beating Wall Street’s revenue expectations, with sales up 5.1% year on year to $364.8 million. On the other hand, next quarter’s revenue guidance of $310 million was less impressive

U.S. stock index futures were muted on Thursday as Nvidia's stellar quarterly results garnered a lukewarm response from investors and downbeat earnings from software company Salesforce weighed on ‌sentiment. Nvidia inched 0.6% higher in premarket trading

Xerox’s stock price has taken a beating over the past six months, shedding 52.5% of its value and falling to $1.82 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.